Location History:
- Frederick, MD (US) (2001)
- Fairfield, PA (US) (1999 - 2007)
Company Filing History:
Years Active: 1999-2007
Title: Mark T Dertzbaugh: Innovator in Biotech Solutions
Introduction
Mark T Dertzbaugh is a notable inventor based in Fairfield, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and vaccines. With a total of 4 patents to his name, Dertzbaugh's work has the potential to impact public health and safety.
Latest Patents
Dertzbaugh's latest patents include groundbreaking work on monoclonal antibodies against ricin toxin. These antibodies were selected for their ability to bind to ricin and its subunits, demonstrating their potential utility in immunodiagnostic applications. The research indicates that these monoclonal antibodies can inhibit ricin-mediated cytotoxicity in vitro, suggesting their use in preventing and treating ricin intoxication in vivo. Another significant patent involves a botulinum neurotoxin vaccine, which utilizes a nontoxic heavy chain fragment from botulinum neurotoxins A-G. This innovation aims to induce a protective immune response against botulinum intoxication.
Career Highlights
Mark T Dertzbaugh is currently employed by the US Government as represented by the Secretary of the Army. His work in this capacity has allowed him to focus on critical research that addresses public health challenges.
Collaborations
Dertzbaugh has collaborated with esteemed colleagues such as John S Lee and Peter M Pushko. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Mark T Dertzbaugh's contributions to biotechnology through his patents and research are noteworthy. His work on monoclonal antibodies and vaccines showcases his commitment to advancing health solutions. Dertzbaugh's innovations hold promise for improving safety and treatment options in the face of biological threats.